Designing Longevity
Skip to main content
All providers

Hone Health vs Maximus: Traditional Injectable TRT vs Fertility-Preserving Oral Protocol

Hone Health and Maximus are the two ends of the hormone-TRT cohort. Hone is the cohort top pick ( Accredited Dec 2023, 4.8/5 across 10,000+ reviews, no fraud notice) running traditional membership-model injectable TRT with bundled ongoing labs. Maximus runs an unconventional oral testosterone + enclomiphene protocol with the only published clinical study in our hormone-TRT cohort, but with the cohort's worst BBB posture (F rating driven by unanswered complaints).

Reviewed by Designing Longevity Editorial·Last verified May 1, 2026

Bottom line

Hone Health for almost every reader. Stronger trust signals across every conventional dimension (, volume, customer service, operational maturity) plus the cleaner protocol most readers expect from TRT telehealth. Choose Maximus only if you specifically want fertility-preserving oral TRT (LH/FSH preserved while testosterone is raised) AND you have read the BBB complaint pattern AND decided you're comfortable with the operational risk. The protocol differentiator is real; the operational risk is also real.

Side-by-side at a glance

Criterion
Hone Health
Maximus
Overall score
3.9/5
3.1/5
Pricing
$129-$149/mo membership + ~$28-$100/mo medication
$99.99/mo enclomiphene-only or $199.99/mo oral testosterone + enclomiphene (annual commitment)
Categories
1 category
1 category
States served
All 50
All 50
Last verified
May 1, 2026
May 1, 2026
Disclosure
No relationship
No relationship

Who wins for each use case

We pick a winner per criterion and explain the reasoning. Skip to whichever rows match how you'd actually use the platform.

  • BBB rating and complaint posture

    Winner: Hone Health

    Hone Health is Accredited since December 29, 2023 with documented complaint responsiveness. Maximus is NOT BBB Accredited and carries an F rating driven by unanswered complaints documenting repeat charges without medication delivery, refund refusals, and unanswered cancellation requests. This is the largest single trust gap in our hormone-TRT cohort.

  • Trustpilot signal quality and volume

    Winner: Hone Health

    Hone has 4.8/5 across 10,000+ reviews with no fraud notice. Maximus has 4.4-4.6/5 across roughly 200-260 reviews. Both are clean (no fraud notices), but the order-of-magnitude larger sample at Hone is meaningfully more informative.

  • Published clinical study evidence

    Winner: Maximus

    Maximus is the only TRT provider in our cohort with a publicly-documented clinical study on its specific protocol (Oral T + Enclomiphene: 4x total testosterone, 5x free testosterone, LH/FSH preserved). Hone Health does not market a comparable published-study evidence base for its protocol. For users who specifically weight clinical-evidence transparency, Maximus wins this row.

  • Fertility preservation

    Winner: Maximus

    Maximus's flagship Oral T + Enclomiphene protocol preserves LH and FSH within normal ranges, unlike traditional injectable TRT which suppresses both. For younger men, men actively trying to conceive, or men who want to preserve testicular function while raising testosterone, this is the differentiated option in our hormone-TRT cohort. Hone Health uses traditional injectable testosterone with the standard LH/FSH suppression that comes with it.

  • Care-model maturity

    Winner: Hone Health

    Hone's membership-model with bundled ongoing labs from month three (quarterly year one, semi-annual after) plus board-certified clinicians is the polished default in our cohort. Maximus has board-certified physicians but the operational delivery is less consistent per complaint patterns documenting service issues. Care-model maturity is the dimension where Hone's cohort-leading trust signals translate to a real day-to-day patient experience advantage.

  • All-in monthly cost

    Winner: Maximus

    Maximus enclomiphene-only at $99.99/mo on annual commitment is the lowest TRT entry point in our cohort, materially below Hone's $157-$249/mo all-in. The Oral T + Enclomiphene protocol at $199.99/mo on annual commitment is roughly comparable to Hone's mid-tier math. The annual-commitment structure is a real caveat, but for cost-sensitive users committing to a year of TRT, Maximus wins on entry-level pricing.

  • Cancellation and refund flow

    Winner: Hone Health

    Hone Health has -documented complaint responsiveness and operational consistency. Maximus has BBB-documented complaint pattern of repeat charges without medication delivery, refund refusals after cancellation, and difficulty reaching a real person. The annual-commitment pricing structure compounds this; if cancellation friction matters to you, Hone is the meaningfully cleaner pick.

  • Compounded footprint and vendor exposure

    Winner: Hone Health

    Hone Health uses standard commercial testosterone formulations through partner pharmacies; not a compounder itself. Maximus has a broader footprint that extends beyond TRT into compounded weight loss medications, oxytocin calming cream, and other compounded protocols, increasing compounder-vendor management exposure during the active 2025-2026 enforcement environment.

Rubric scores side-by-side

Same six dimensions we use on every provider profile, weighted to a single 0-5 score. Click through to either profile for the verification details behind each row.

Licensure 20% weight

Hone Health4.0
Maximus3.5

Accreditation 20% weight

Hone Health4.0
Maximus1.5

Transparency 20% weight

Hone Health4.0
Maximus4.0

Product quality 15% weight

Hone Health3.5
Maximus3.5

Pricing 15% weight

Hone Health3.5
Maximus4.0

Customer service 10% weight

Hone Health4.0
Maximus2.0

Pricing in plain terms

Hone: $129-$149/mo membership + $28-$100/mo medication, all-in $157-$249/mo with bundled labs from month three. Maximus: $99.99/mo enclomiphene-only or $199.99/mo Oral T + Enclomiphene with annual commitment baked into the headline rates. Maximus wins on entry-level pricing if you commit annually; Hone wins on operational consistency, cancellation flow, and bundled labs. Decision rule: traditional injectable TRT with the cohort-cleanest operational profile -> Hone; fertility-preserving oral protocol with annual-commitment pricing -> Maximus, with caveats acknowledged.

Read the full profiles

This comparison summarizes the head-to-head call. The full provider profiles include verification items, regulatory history, public-review aggregation, and the signup walkthrough.